CANC (CANC) Stock Price & Analysis
CANC (CANC) rose 2.46% to USD 37.32 as of June 11, 2026 at 19:13 UTC, according to Nexqual real-time market data.
CANC last closed at USD 36.43; the session ranged USD 36.37–37.32 on volume of 7,815 shares. Market capitalization is —, with a 52-week range of USD 23.49–39.95 (NGM). Source: Nexqual, June 11, 2026 at 19:13 UTC.
Key Statistics (as of June 11, 2026 at 19:13 UTC)
| Price | USD 37.32 |
|---|---|
| Change | ▲ 2.46% (up) |
| Previous Close | USD 36.43 |
| Open | USD 36.77 |
| Day Range | USD 36.37 – 37.32 |
| 52-Week Range | USD 23.49 – 39.95 |
| Volume | 7,815 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (CANC)
Nexqual's technical model rates CANC "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of June 11, 2026 at 19:13 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.36 (neutral) |
| vs SMA50 | Below (USD 37.68) |
| MACD | -0.25 (negative) |
Financial Health Score (CANC)
Nexqual rates CANC's overall financial health "Mixed" across five dimensions, as of June 11, 2026 at 19:13 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HRTS | Tema Heart & Health ETF | USD 34.42 | ▲ 0.51% |
| RSHO | Tema U.S. Manufacturing & Resho | USD 58.41 | ▼ 0.44% |
| IBBQ | Invesco Nasdaq Biotechnology ET | USD 29.46 | ▲ 0.72% |
| FMED | Fidelity Disruptive Medicine ET | USD 25.39 | ▲ 0.71% |
| AGNG | Global X Aging Population ETF | USD 35.17 | ▲ 0.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 19:13 UTC. This page is informational and not investment advice.